Impact of vitamin D-related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium/PTH reference regions

Clinical Endocrinology

Volumn 76, Issue 6, 2012, Pages 785-789

  Fillée, Catherine ^a   Keller, Thomas ^b   Mourad, Michel ^a   Brinkmann, Thomas ^c   Ketelslegers, Jean Marie ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b ACOMED Statistik   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CREATININE; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUMMER; WINTER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CALCIUM; CREATININE; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROID HORMONE; VITAMIN D; YOUNG ADULT;

EID: 84860155528     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04285.x     Document Type: Article

References (14)

1. Eastell, R., Arnold, A., Brandi, M.L., et al. (2009) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Journal of Clinical Endocrinology and Metabolism, 94, 340-350.
2. Nussbaum, S.R., Zahradnik, R.J., Lavigne, J.R., et al. (1987) Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clinical Chemistry, 33, 1364-1367.
3. Souberbielle, J.C., Lawson-Body, E., Hammadi, B., et al. (2003) The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. Journal of Clinical Endocrinology and Metabolism, 88, 3501-3504.
4. Aloia, J.F., Feuerman, M., &, Yeh, J.K., (2006) Reference range for serum parathyroid hormone. Endocrine Practice, 12, 137-144.
5. Rejnmark, L., Vestergaard, P., Heickendorff, L., et al. (2011) Determinants of plasma PTH and their implication for defining a reference interval. Clinical Endocrinology, 74, 37-43.
6. Solberg, H.E., (1996) Establishment and use of reference values. In:, C.A. Burtis, E.R. Ashwood, eds. Tietz. Fundamentals of Clinical Chemistry, 4th edn. W.B. Saunders Company, Philadelphia, 182-191.
7. Gräsbeck, R., &, Alstöm, T., (1981) Reference Values in Laboratory Medicine: The Current State of the Art. John Wiley & Sons, Chichester, England, 1-413.
8. Boyd, J.C., &, Lacher, D.A., (1982) The multivariate reference range: an alternative interpretation of multi-test profiles. Clinical Chemistry, 28, 259-265.
9. Roth, H.J., Schmidt-Gayk, H., Weber, H., et al. (2008) Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Annals of Clinical Biochemistry, 45, 153-159.
10. Binkley, N., Krueger, D., Cowgill, C.S., et al. (2004) Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. Journal of Clinical Endocrinology and Metabolism, 89, 3152-3157.
11. Binkley, N., Krueger, D., Gemar, D., et al. (2008) Correlation among 25-hydroxy-vitamin D assays. Journal of Clinical Endocrinology and Metabolism, 93, 1804-1808.
12. Lips, P., Chapuy, M.C., Dawson-Hughes, B., et al. (1999) An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporosis International, 9, 394-397.
13. Silverberg, S.J., Gao, P., Brown, I., et al. (2003) Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 88, 4725-4730.
14. Silverberg, S.J., Lewiecki, E.M., Mosekilde, L., et al. (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Journal of Clinical Endocrinology and Metabolism, 94, 351-365.